New Therapeutics to Treat Castrate-Resistant Prostate Cancer

The effective treatment of castrate-resistant prostate cancer (CRPC) has proven to be very challenging. Until recently, docetaxel was the only therapeutic demonstrated to extend overall patient survival. Yet recently, a considerable number of new therapeutics have been approved to treat CRPC patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Acar, Ömer, Esen, Tarık, Lack, Nathan A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3678432/
https://www.ncbi.nlm.nih.gov/pubmed/23781155
http://dx.doi.org/10.1155/2013/379641

Ejemplares similares

Ejemplares similares